2-[2-(2-Methoxyphenoxy)ethyl]-1H-isoindole-1,3(2H)-dione

We are 2-[2-(2-Methoxyphenoxy)ethyl]-1H-isoindole-1,3(2H)-dione CAS:26646-63-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   2-[2-(2-Methoxyphenoxy)ethyl]-1H-isoindole-1,3(2H)-dione
CAS.NO:26646-63-9
Synonyms:
[2-(2-methoxy-phenoxy)-ethyl]-benzyl-amine
N-(2-(2-METHOXYPHENOXY)ETHYL)BENZYLAMINE
Benzenemethanamine,N-[2-(2-methoxyphenoxy)ethyl]
benzyl[2-(2-methoxyphenoxy)ethyl]amine
N-Benzyl-2-(2-methoxyphenoxy)ethylamine

Molecular Formula:C17H15NO4
Molecular Weight:297.30500

Physical and Chemical Properties:
Density:1.278±0.06 g/cm3
Boiling point: 449.5±25.0 °C(Predicted)
Melting point: 102-108 °C
Flash point: /
Refractive index: /

Specification:
Appearance: solid
Purity:≥98%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Carvedilol phosphate CAS:610309-89-2
Intermediates of Carvedilol CAS:72956-09-3

2-[2-(2-Methoxyphenoxy)ethyl]-1H-isoindole-1,3(2H)-dione


Related News: Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.4-(methylsulfanyl)phenol “Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.Isopropil 2-bromo-2-metilpropanoato CAS:51368-55-9 With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near9- (4-bromofenil) carbazol CAS:57102-42-8 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.

Related Products
Product Name
2-(4-bromophenyl)triphenylene View Details
L-proline methylester hydrochloride View Details
(3R)-1-azabicyclo[2.2.2]octan-3-ol View Details
4-(trifluoromethyl)phenol manufacturer o-Tolunitrile manufacturer Human GLP-1 (7-37) manufacturer 2-Chloro-4-fluorobenzaldehyde manufacturer potassium hydroxide manufacturer